[61] prepared TME-targeted NPs by self-assembly of Zn2+ with pIC (polycytidylic aid), which was able to activate the TRL3 pathway and significantly enhance the tumor therapeutic effect of αPD-L1: the percentage of CD8+ T cells, DCs, and macrophages in tumors was significantly increased. The gene discussed is CD8A; the disease is neoplasm.